Ongoing provincial government support for the Ontario Institute for Regenerative Medicine (OIRM) is critical to maintain Ontario's global competitiveness in the fast-growing field of regenerative medicine which is developing cutting-edge products and therapies resulting from stem cell research, Dr. Duncan Stewart, president and scientific director of OIRM, and Dr. Tim Smith, chair of the board of directors at OIRM, say in an op-ed.